文献速递免疫规划传染病防控与疫情报告

波兰儿童青少年全细胞与无细胞百日咳疫苗初免的保护持久性

Duration of protection against Bordetella pertussis infection elicited by whole-cell and acellular vaccine priming in Polish children and adolescents.
PubMed 文献 · Vaccine · 2021-09-10

该研究基于波兰2745名≥5岁且<16岁、已完成5剂百日咳疫苗系列的儿童青少年血清样本,按初免疫苗类型(全细胞wP或无细胞aP)分层,以抗百日咳毒素抗体浓度作为近期感染的替代指标。结果显示,两组在学龄前加强剂后8年起均出现抗体水平再升高,提示近期感染,且再升高的时间与强度在两组间无显著差异。

要点

  • 完成5剂百日咳疫苗系列的青少年中,疫苗诱导的免疫保护随时间减弱。
  • 全细胞与无细胞百日咳疫苗初免后,保护减弱的时间与强度相似。
  • 学龄前加强剂后8年起,两组均出现抗PT抗体再升高,提示近期感染。

核心结论

  • 疫苗诱导的百日咳免疫在青少年中减弱,即使完成婴儿、幼儿和学龄前加强系列。
  • 全细胞与无细胞百日咳疫苗初免后保护减弱的时间与强度相似。

研究设计与样本

  • 研究纳入2745名≥5岁且<16岁、已完成5剂百日咳疫苗系列的儿童青少年。
  • 采用ELISA检测百日咳毒素抗体,按初免疫苗类型(wP或aP)分层分析。

主要发现

  • 1161名(42.5%)儿童初免和幼儿加强使用wP疫苗,1314名(48.1%)使用aP疫苗。
  • 53.57%的受试者及时接种第2-4剂,仅41.52%按推荐间隔完成全部5剂。
  • 两组在学龄前加强剂后8年起抗PT抗体水平再升高,提示近期感染,时间与强度无显著差异。

临床怎么用

  • 监测青少年百日咳抗体水平变化,关注学龄前加强剂后8年起的感染信号。
  • 评估疫苗保护持久性时需考虑初免疫苗类型及接种及时性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: In the context of reported resurgence of pertussis in the last decade, researchers hypothesized that acellular (aP) pertussis vaccines elicit a shorter-lived protection compared to whole-cell (wP) pertussis vaccines. However, in the studies seeking to demonstrate this hypothesis, exposure to each vaccine type was not concurrent, and contradictory epidemiologic modeling questioned its validity. The context of pertussis vaccination history in Poland, with both vaccine types used concurrently in comparable proportions, provided an opportunity to investigate this hypothesis. We sought to compare waning of protection by primary series vaccine type by measuring anti-pertussis toxin antibody concentrations as proxy for recent infection. MATERIALS AND METHODS: Serological samples from 2,745 children and adolescents aged ≥5 years and <16 years and with completed 5-dose pertussis vaccination series were tested by ELISA for pertussis toxin (PT) antibodies. Participants were stratified by type of priming vaccine (wP or aP). Vaccination timeliness and priming-specific trends in anti-PT antibody levels by time since last vaccine dose were analyzed. RESULTS: A total of 1,161 (42.5%) children received wP vaccines, and 1,314 (48.1%) received aP vaccines for their primary series and toddler booster. Overall, 53.57% of the subjects received doses 2-4 in a timely manner, while only 41.52% received all 5 doses at the recommended intervals. Using GMCs or seropositivity measures, both priming groups showed a re-increase in anti-PT antibody levels signing infection in recent years from 8 years after the school-entry booster onward. Comparisons did not show any significant differences between the two groups in the timing or intensity of this re-increase. CONCLUSION: Our results clearly confirm that vaccine-elicited immunity against pertussis wanes among adolescents even after a complete infant, toddler and school-entry vaccination series. The timing and intensity of the waning of protection appear similar with whole-cell as with acellular pertussis vaccines.

来源:Vaccine,查看原文。版权归原作者所有。

引用

  1. Paradowska-Stankiewicz I, Rumik A, Bogusz J, et al. Duration of protection against Bordetella pertussis infection elicited by whole-cell and acellular vaccine priming in Polish children and adolescents. Vaccine. 2021. PMID: 34511302. doi:10.1016/j.vaccine.2021.08.105

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。